Literature DB >> 19252778

Sex differences in the prognostic value of the lipid profile after the first ischemic stroke.

E Cuadrado-Godia1, J Jiménez-Conde, A Ois, A Rodríguez-Campello, E García-Ramallo, J Roquer.   

Abstract

Post-stroke levels of total cholesterol (TC) appear to be negatively associated with stroke mortality. Statin pretreatment might affect this association. Sex differences in the prognostic value of the lipid profile have not yet been studied. We have evaluated the impact of TC, high- and low-density lipoprotein (HDL and LDL, respectively), and triglyceride (TG) levels on the 3-month outcome after a first ischemic stroke (IS) according to sex and previous statin use. The study group consisted of a hospital-based cohort of consecutive patients with a diagnosis of first IS. Poor outcome was defined as a modified Rankin Scale (mRS) score >or=3 at 90 days. The odds ration (OR) for poor prognosis was analyzed for each sex using logistic regression models adjusted for vascular risk factors and statin pretreatment. A total of 591 patients were included in the analysis (318 men). The predictors of a 90-day poor outcome were age and initial NIH Stroke Scale (NIHSS) score in women, and age, initial NIHSS, smoking, atrial fibrillation, and thrombolytic treatment in men. In women, none of the lipids studied affected the 90-day prognosis. Men falling in the last quintile of TC [OR: 0.68 95% confidence interval (95% CI) 0.52-0.88; p = 0.004] and LDL (OR 0.74, 95% CI 0.56-0.98; p = 0.04) have better outcome than men in the first quintile. Adjusting for statin pretreatment did not change the results. The results indicated that an association between poststroke lipids and prognosis may vary by sex. In women, lipids were not associated with the outcome; in men, lower TC and LDL were associated with worse prognosis. These differences can not be explained by statin use and require further research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252778     DOI: 10.1007/s00415-009-5059-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial.

Authors:  L B Goldstein; G P Samsa
Journal:  Stroke       Date:  1997-02       Impact factor: 7.914

2.  Effect of pretreatment with statins on ischemic stroke outcomes.

Authors:  Mathew J Reeves; Julia Warner Gargano; Zhehui Luo; Andrew J Mullard; Bradley S Jacobs; Arshad Majid
Journal:  Stroke       Date:  2008-03-27       Impact factor: 7.914

3.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

4.  Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality.

Authors:  Mitchell S V Elkind; Alexander C Flint; Robert R Sciacca; Ralph L Sacco
Journal:  Neurology       Date:  2005-07-26       Impact factor: 9.910

5.  Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage.

Authors:  J Roquer; A Rodríguez Campello; M Gomis; A Ois; E Munteis; P Böhm
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

Review 6.  Impact of gender on statin efficacy.

Authors:  Krista M Dale; Craig I Coleman; Sachin A Shah; Aarti A Patel; Jeffrey Kluger; C Michael White
Journal:  Curr Med Res Opin       Date:  2007-03       Impact factor: 2.580

7.  Discontinuation of statin therapy and clinical outcome after ischemic stroke.

Authors:  Furio Colivicchi; Andrea Bassi; Massimo Santini; Carlo Caltagirone
Journal:  Stroke       Date:  2007-08-30       Impact factor: 7.914

8.  Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke.

Authors:  Christopher J Weir; Naveed Sattar; Matthew R Walters; Kennedy R Lees
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Sex differences in first-ever acute stroke.

Authors:  Jaume Roquer; Ana Rodríguez Campello; Meritxell Gomis
Journal:  Stroke       Date:  2003-06-12       Impact factor: 7.914

View more
  10 in total

1.  Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use: A population-based study.

Authors:  Samrat Yeramaneni; Dawn O Kleindorfer; Heidi Sucharew; Kathleen Alwell; Charles J Moomaw; Matthew L Flaherty; Daniel Woo; Opeolu Adeoye; Simona Ferioli; Felipe de Los Rios La Rosa; Sharyl Martini; Jason Mackey; Pooja Khatri; Brett M Kissela; Jane C Khoury
Journal:  Int J Stroke       Date:  2016-09-24       Impact factor: 5.266

2.  Prognostic significance of major lipids in patients with acute ischemic stroke.

Authors:  Konstantinos Tziomalos; Vasilios Giampatzis; Stella D Bouziana; Marianna Spanou; Stavroula Kostaki; Maria Papadopoulou; Stella-Maria Angelopoulou; Maria Tsopozidi; Christos Savopoulos; Apostolos I Hatzitolios
Journal:  Metab Brain Dis       Date:  2016-10-23       Impact factor: 3.584

3.  The total cholesterol to high-density lipoprotein cholesterol as a predictor of poor outcomes in a Chinese population with acute ischaemic stroke.

Authors:  Lifang Chen; Jianing Xu; Hao Sun; Hao Wu; Jinsong Zhang
Journal:  J Clin Lab Anal       Date:  2017-01-26       Impact factor: 2.352

4.  Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke.

Authors:  Jordi Jimenez-Conde; Alessandro Biffi; Rosanna Rahman; Allison Kanakis; Christi Butler; Shruti Sonni; Efi Massasa; Lisa Cloonan; Aaron Gilson; Karen Capozzo; Lynelle Cortellini; Angel Ois; Elisa Cuadrado-Godia; Ana Rodriguez-Campello; Karen L Furie; Jaume Roquer; Jonathan Rosand; Natalia S Rost
Journal:  Stroke       Date:  2010-02-04       Impact factor: 7.914

5.  Biomarkers and functional outcomes from ischaemic cerebral events in women: a prospective cohort study.

Authors:  P M Rist; J E Buring; C S Kase; P M Ridker; T Kurth
Journal:  Eur J Neurol       Date:  2012-10-03       Impact factor: 6.089

6.  Correlative study between neuron-specific enolase and blood sugar level in ischemic stroke patients.

Authors:  Aparna Pandey; Kiran Saxena; Meena Verma; Anuradha Bharosay
Journal:  J Neurosci Rural Pract       Date:  2011-01

Review 7.  Statins in Acute Ischemic Stroke: A Systematic Review.

Authors:  Keun-Sik Hong; Ji Sung Lee
Journal:  J Stroke       Date:  2015-09-30       Impact factor: 6.967

Review 8.  DNA Methylation in Stroke. Update of Latest Advances.

Authors:  Jerzy Krupinski; Caty Carrera; Elena Muiño; Nuria Torres; Raid Al-Baradie; Natalia Cullell; Israel Fernandez-Cadenas
Journal:  Comput Struct Biotechnol J       Date:  2017-12-09       Impact factor: 7.271

9.  Association Between Low-Density Lipoprotein Cholesterol (LDL-C) Level and Unfavorable Outcomes in Participants of Ischemic Stroke without Diabetes: A Multi-Center Retrospective Study.

Authors:  Shan Zhao; Yuanmeng Tian; Han Yan; Boqiang Zhang; Jing Li; Liying Xing; Lei Liu
Journal:  Med Sci Monit       Date:  2019-08-09

10.  Apolipoprotein A1-Unique Peptide as a Diagnostic Biomarker for Acute Ischemic Stroke.

Authors:  Xu Zhao; Yue Yu; Wenlong Xu; Lei Dong; Yuan Wang; Bing Gao; Guangyu Li; Wentao Zhang
Journal:  Int J Mol Sci       Date:  2016-03-28       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.